Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Goiter, Substernal
The oncologic efficacy of extended thoracic resections.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The oncologic efficacy of extended thoracic resections.
Kader S, Watkins A, Servais EL. The oncologic efficacy of extended thoracic resections. J Surg Oncol. 2023 Feb; 127(2):288-295.
View in:
PubMed
subject areas
Humans
Lung Neoplasms
Pneumonectomy
Thoracic Wall
authors with profiles
elliot L Servais MD
Ammara Abbasi Watkins MD, MPH